Fig. 2From: Global retrospective analysis of clinician- and patient-reported clinical characteristics and humanistic burden of patients with gastroesophageal cancers on first-line treatmentEQ-VAS scores for patients with GC/GEJC/EAC, HER2 status negative/unknown, on first-line treatment. EAC, esophageal adenocarcinoma; EQ-VAS, EuroQol-Visual Analogue Scale; GC, gastric cancer; GEJC, gastroesophageal junction cancer; UK, United Kingdom; US, United StatesBack to article page